Clinical Trials
2 trialsNCT01020292 2019-04-12
A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT00694837 2015-04-10
Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma
Maastricht Radiation Oncology
Phase 1 Completed